The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
After weathering a historically volatile month in March, trading activity on OTC Markets abated somewhat in April, reflecting a relative calmness in market conditions compared to the previous month.
Trading volume on OTC Markets decreased in April, and nearly all of the market’s most actively traded securities experienced month-over-month volume declines as market volatility normalized a bit during the month. Volume on the OTCQX Market—the top tier of OTC Markets— fell 37% in April, while volume on the OTCQB Venture Market decreased 24%.
On an individual company level, nearly all of the most actively traded securities on OTC Markets experienced lighter dollar volume in April than in March, a likely result of lower share prices combined with lower volatility. This includes names like Roche Holding Ltd RHHBY (down 39%), the Grayscale Bitcoin Trust GBTC (down 21%), and Adidas AG ADDYY (down 70%).
Of the 30 most-traded securities on the OTCQX Market, only Air Canada ACDVF (up 38%) and New Pacific Metals Corp. NUMF (up 27%) saw a dollar volume increase in April, while Cresco Labs Inc. CRLBF was flat month-over-month.
On the OTCQB Venture Market, CytoDyn Inc. CYDY was the most actively traded security on the market for the first time on record, as dollar volume in the issuer increased 191%. This massive increase is most likely related to the company’s Leronlimab, which is currently in the Phase 2 testing period to potentially treat severely-ill COVID-19 patients.
Shares of CytoDyn were so actively traded during April, that they accounted for nearly half of all dollar volume on the entire OTCQB Market.
Below are the top 10 most actively traded securities on the OTCQX and OTCQB Markets in April.
OTCQX
| Company Name | Symbol | April Dollar Volume |
|---|---|---|
| Roche Holding Ltd | RHHBY |
$2,615,581,174 |
| Grayscale Bitcoin Trust | GBTC |
$760,608,164 |
| Danone | DANOY |
$574,453,094 |
| BNP Paribas | BNPQY |
$205,399,081 |
| adidas AG | ADDYY |
$154,774,466 |
| Infineon Technologies AG | IFNNY |
$143,502,849 |
| AXA | AXAHY |
$137,990,439 |
|
Heineken N.V. |
HEINY |
$108,282,669 |
| BASF SE | BASFY |
$101,093,324 |
| Anglo American plc | NGLOY | $96,483,869 |
OTCQB
| Company Name | Symbol | April Dollar Volume |
|---|---|---|
| CytoDyn Inc. | CYDY |
$612,566,094 |
| Fannie Mae | FNMA |
$167,514,566 |
| Freddie Mac | FMCC |
$70,217,890 |
| Semler Scientific, Inc. | SMLR |
$17,035,296 |
| Kraig Biocraft Laboratories, Inc. | KBLB |
$15,406,687 |
| Innovation Pharmaceuticals Inc. | IPIX |
$11,881,969 |
| CV Sciences, Inc. | CVSI |
$11,114,943 |
| Algernon Pharmaceuticals Inc. | AGNPF |
$9,325,406 |
| Northwest Biotherapeutics, Inc. | NWBO |
$7,364,351 |
| Nextech AR Solutions Corp. | NEXCF |
$5,945,239 |
The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
